Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8945894 | Respiratory Medicine | 2018 | 7 Pages |
Abstract
The introduction of LAMA/LABA combination products led to population-level changes in regimens used for COPD therapy, but no overall increase in long-acting therapy use. New users of LAMA/LABA and LAMAÂ +Â LABA regimens transitioned to dual LAMA and LABA therapy through different treatment pathways.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Lianne Parkin, Wayne Khuu, Matthew B. Stanbrook, Mina Tadrous, Diana Martins, Tara Gomes,